Erratum: Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma

Errata

This article corrects:

  1. Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma Volume 117, Issue 10, 2112–2119, Article first published online: 29 November 2010

The author list for this article inadvertently omitted one key author (Faye M. Johnson, MD, PhD) and should be corrected as follows: Heather D. Brooks, MD1; Bonnie S. Glisson, MD2; Nebiyou Bekele, MD3; Faye M. Johnson, MD, PhD2; Lawrence E. Ginsberg, MD4; Adel El-Naggar, MD5; Kirk S. Culotta, MD6; Naoko Takebe, MD7; John Wright, MD7; Hai T. Tran, MD2; Vassiliki A. Papadimitrakopoulou, MD2.

The authors regret this error.

Ancillary